Mayo Clinic Platform_Accelerate Announces New AI Health Tech Cohort

The program provides participants with access to Mayo Clinic’s network of expert mentors, industry-leading technologies, and millions of de-identified, longitudinal clinical records.

Mayo Clinic Platform_Accelerate has announced its latest cohort of 11 health tech startups that will participate in an immersive, 30-week program focused on developing and validating artificial intelligence (AI)-driven healthcare solutions.

The program provides participants with access to Mayo Clinic’s network of expert mentors, industry-leading technologies, and millions of de-identified, longitudinal clinical records.

The selected startups, spanning national and international origins, will also engage with top investors and healthcare leaders to help scale their ventures.

“The only way we can transform healthcare is by bringing together clinical experts with technology innovators,” said John Halamka, M.D., Diercks president of Mayo Clinic Platform. “Our Accelerate program connects innovative startups with Mayo Clinic physicians and scientists to turn breakthrough ideas into real-world healthcare solutions.”

The new cohort includes:

• Bowhead Health – developing a radiogenomics platform using imaging to predict genomic mutations and guide personalized treatment and clinical trial matching.

• Cleancard – creating an AI-powered, at-home cancer detection test delivering lab-grade diagnostics in 30 minutes.

• Dart Health – deploying hospital-wide AI solutions by embedding engineering teams on-site to address clinical and operational challenges.

• Kanjo Health – using AI and evidence-based insights to provide early, personalized care for children with ADHD and autism.

• Koroid – predicting clinical demand and automating healthcare logistics for efficient, safe, and quality-driven care.

• MedLink Global – advancing AI-driven precision psychiatry with tools for accurate diagnoses and personalized treatment.

• MyAtlas Health – leveraging AI and wearable data to predict mental health crises early and deliver preventive support.

• Ordinatrum Health – enhancing critical care through AI-powered, FDA-cleared virtual ICUs and data integration.

• Promed AI – combining at-home testing and multimodal AI to deliver affordable, personalized preventive healthcare.

• RTHM – improving diagnosis and treatment for complex chronic illnesses, including long COVID and chronic fatigue syndrome.

• Radical – developing a general-purpose AI model for oncology that generates personalized treatment recommendations to improve outcomes and reduce costs.

“We're proud to welcome our October cohort, 11 companies pushing the boundaries of AI in healthcare,” said Jamie Sundsbak, director of the Accelerate program. “Their energy and vision reflect the very spirit of Accelerate: bold innovation, deep collaboration, and a relentless focus on patient impact. Our team is honored to support their journey and excited to see what they build next.”

Stay tuned for more such updates on Digital Health News